FOURTH SUPPLEMENTAL INDENTUREFourth Supplemental Indenture • January 9th, 2023 • Quotient LTD • In vitro & in vivo diagnostic substances • New York
Contract Type FiledJanuary 9th, 2023 Company Industry JurisdictionTHIS FOURTH SUPPLEMENTAL INDENTURE (this “Supplemental Indenture”) dated as of January 4, 2023, among Quotient Limited (or its successor), a limited liability no par value company incorporated under the laws of Jersey, Channel Islands (the “Company”), the Guarantors party hereto, and Wilmington Savings Fund Society, FSB, as trustee (the “Trustee”) under the indenture referred to below.